$3.87
+0.02 (+0.52%)
Open$3.85
Previous Close$3.85
Day High$3.92
Day Low$3.84
52W High$9.33
52W Low$3.59
Volume—
Avg Volume305.7K
Market Cap346.25M
P/E Ratio—
EPS$-1.94
SectorPharmaceuticals
Analyst Ratings
Buy
10 analysts
Price Target
+422.5% upside
Current
$3.87
$3.87
Target
$20.22
$20.22
$15.45
$20.22 avg
$24.58
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 511.05M | 417.62M | 70.84M |
| Net Income | -194,091,901 | -142,749,620 | 13.06M |
| Profit Margin | -38.0% | -36.1% | 18.4% |
| EBITDA | -93,741,624 | -72,774,816 | 20.07M |
| Free Cash Flow | — | — | 11.95M |
| Rev Growth | +22.4% | +22.4% | +2.1% |
| Debt/Equity | 0.05 | 0.05 | 0.16 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |